Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Raw Materials (2016 - 2026)

Bio-Techne has reported Raw Materials over the past 16 years, most recently at $96.2 million for Q4 2025.

  • For Q4 2025, Raw Materials rose 14.58% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $96.2 million, up 14.58%, while the annual FY2025 figure was $89.1 million, 12.22% up from the prior year.
  • Raw Materials for Q4 2025 was $96.2 million at Bio-Techne, up from $94.0 million in the prior quarter.
  • Over five years, Raw Materials peaked at $96.2 million in Q4 2025 and troughed at $51.7 million in Q1 2021.
  • A 5-year average of $78.2 million and a median of $82.5 million in 2023 define the central range for Raw Materials.
  • Biggest five-year swings in Raw Materials: soared 43.91% in 2022 and later dropped 7.45% in 2024.
  • Year by year, Raw Materials stood at $61.6 million in 2021, then soared by 37.54% to $84.8 million in 2022, then fell by 1.78% to $83.2 million in 2023, then rose by 0.86% to $84.0 million in 2024, then increased by 14.58% to $96.2 million in 2025.
  • Business Quant data shows Raw Materials for TECH at $96.2 million in Q4 2025, $94.0 million in Q3 2025, and $89.1 million in Q2 2025.